Fig. 2From: RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNAMechanisms of siRNA versus shRNA. shRNA may be episomal or integrate into the genome via lentiviral transfection for greater stability. Both pathways converge at the RISC complexBack to article page